Scientist, Neuropharmacology
- Organization:
- HELICON THERAPEUTICS, INC.
Helicon Therapeutics is seeking an experienced Neuroscientist with expertise in rodent in vivo microdialysis. The candidate will be responsible for the design and execution of experiments to measure pharmacodynamic effects of novel small molecules that enhance cognition and to explore possible CNS biomarkers. A scientific background in learning and memory, neurotransmitter pathways, synaptic plasticity and GPCR biology is desired. The candidate will design and execute in vivo experiments, provide scientific and creative leadership, demonstrate excellent communication and interpersonal skills and may be responsible for supervision of Research Associates. The selected candidate will be working in a creative, fast-paced environment, interacting with scientists from other disciplines, such as biology, high throughput screening, synthetic and medicinal chemistry. The position demands team-oriented execution of time-dependent experiments. Thus, the candidate must have excellent interpersonal skills and must be organized and timely with regard to data collection, meeting presentations and study reports.
Desired Skills & Experience
- Ph.D. in neurobiology or pharmacology with 5+ years postgraduate research experience, preferably industrial
- Extensive knowledge and hands-on experience in in vivo microdialysis, CNS disease models, biomarker development and compound screening
- Able to work independently and mentor and train junior staff
- Strong background in statistical analysis and study design
- Contribute scientific input to research programs
- Motivated team player with a can-do attitude
- Good management, oral and written communication skills
Company Description
HELICON THERAPEUTICS, INC., is a privately held Company formed to discover therapeutics to treat disorders of cognition through an understanding of the genetic basis of long-term memory formation.
Helicon's mission is to become the leading specialized pharmaceutical company for memory disorders by focusing on the discovery and development of innovative drugs with new mechanisms of action. These discoveries are firmly based in a careful examination of the genes involved in the reorganization of synaptic connections in brain, a cellular/molecular process which underlies both implicit (motor skills) and explicit (facts and events) forms of memory.